Dr. Elhamy Eskander, MD
1562 Opossumtown Pike, Frederick, MD 21702 • +1-550-555-6609
Medical Education: Accredited U.S. Medical School (Class of 2012)
What This Doctor Actually Performs: CMS Medicare Utilization & Frederick Percentiles
NPI #1528050473 • CBSA Regional • Hematology-Oncology
Dr. Elhamy Eskander, MD (NPI #1528050473) practices Hematology-Oncology in Frederick, MD (21702) with sub-specialty concentration in 163 Active CMS HCPCS Codes, recording 195,010 annual CMS services across 899 distinct beneficiaries—placing this practice as a mid-cohort balanced caseload (42.86th Frederick percentile) (+0.54σ vs MD state mean, 73.33th statewide percentile).
Granular CPT/HCPCS billing distribution at 1562 Opossumtown Pike shows Dr. Elhamy Eskander's primary concentration in Moderate-to-High Complexity Internal Medicine Follow-Up (code 99214: 1665x/yr, 42.86th local percentile) alongside Established Preventive & Chronic Care Visit (99213: 962x/yr, $33–$48).
Cash-pay intake data for NPI 1528050473 (1562 Opossumtown Pike, Frederick) indicates $209.00 typical out-of-pocket visit spend against a $209.00 locality benchmark, paired with 11-minute average reception wait and 4.83/5 biomarker openness.
Credentialed as an MD specialist with 14 years post-graduation experience since completing medical school at an LCME/COCA institution (2012), Dr. Eskander coordinates 163 Active CMS HCPCS Codes workups from 1562 Opossumtown Pike (+1-550-555-6609).
Compared against Frederick, MD Hematology-Oncology peers
195,010 annual services across 899 beneficiaries
Standard deviations from MD Hematology-Oncology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 1,665 | 42.86th | $43 – $60 |
| 99213 | Established Preventive & Chronic Care Visit | 962 | 43.86th | $33 – $48 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 481 | 43.86th | $25 – $40 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 370 | 43.86th | $51 – $70 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 222 | 37.86th | $60 – $83 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (163 HCPCS billing breadth) | 191,310 | 42.86th | $45 – $65 |
Are you Dr. Elhamy Eskander? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Frederick, MD:
<a href="https://dotmd.com/doctors/elhamy-eskander-md-frederick-md-1528050473" title="Dr. Elhamy Eskander, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1528050473.svg" alt="Dr. Elhamy Eskander Hematology-Oncology Badge" width="280" height="72" /></a>
Dr. Elhamy Eskander, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Eskander National Provider Identifier | NPI #1528050473 (MD) | CMS NPPES Registry (21702) |
| Dr. Eskander Frederick CMS Volume Rank | 42.86th Pct (195,010 CMS svcs; Z +0.536σ) | CMS Medicare Part B (MD Hematology-Oncology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Frederick, MD) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 11 min lobby wait | 5 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.76/5 Listening • 4.83/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Elhamy Eskander
Other High-Volume Hematology-Oncology Specialists in Frederick, MD
Ranked strictly by CMS Medicare volumeDr. Eskander Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Frederick, MD.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Elhamy Eskander community threads and patient logs by age, biological sex, dosage, and treatment duration.